Prosecution Insights
Last updated: August 17, 2026

Ramot At Tel-aviv University Ltd.

44 pending office actions • 29 art units • 41 examiners • 0 of 44 (0%) have an AI response strategy ready • 30 patents granted in the last 365 days

Portfolio Summary

44
Total Pending OAs
24
Non-Final OAs
17
Final Rejections
3
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 16 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
8
Due this month
2
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 16 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 30 days (8)Due ≤ 60 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

26
Hard (59%)
13
Medium (30%)
5
Easy (11%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other4 (9%)
§103 only12 (27%)
§102 only1 (2%)
§112 only5 (11%)
Multi-statute (no §101)22 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

31
Life Sciences
70% of docket
1
Information Tech
2% of docket
1
Communications
2% of docket
2
Semiconductors
5% of docket
3
Mechanical / Eng
7% of docket
6
Business / Other
14% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

440 h
Manual time on pending OAs
88 h
Time saved (low, 20%)
154 h
Time saved (mid, 35%)
3.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SZNAIDMAN, MARCOS L 2 37.2% +16.0%
LEONARD, ARTHUR S 2 50.9% +50.5%
MIDDLETON, DANAYA L 2 46.1% +54.1%
YANG, JEFFREY ANDREW 1 85.7% +26.3%
LEBOEUF, JEROME LARRY 1 85.2% +7.2%
ROMERO, KRISTEN WANG 1 70.7% +30.0%
TOTH, KAREN E 1 46.7% +25.4%
COUGHLIN, DANIEL F 1 39.0% +18.5%
YOUNGBLOOD, WILLIAM JUSTIN 1 61.9% +40.0%
HO, WAI-GA DAVID 1 14.3% +100.0%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19071967 FOUNDATION MODEL FOR ERROR CORRECTION CODES AND LEARNING LINEAR BLOCK ERROR CORRECTION CODES YANG, JEFFREY ANDREW

Hard Cases (27)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17780536 COMPOSITION-OF-MATTER FOR EXTRUSION OF ELECTROCHEMICAL SYSTEM SMITH, JEREMIAH R 42d overdue
17675910 PEPTIDES FOR THE TREATMENT OF RENAL DISORDERS COFFA, SERGIO 30d overdue
18605474 COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASE NEAGU, IRINA 4d overdue
17870029 MOLECULES AND METHODS FOR INCREASED TRANSLATION ABBOTT, KODYE LEE 12d
17831232 INTEGRATED DRUG DISCOVERY PLATFORM FOR PROTEIN MISFOLDING DISORDERS ASSOCIATED WITH METABOLITE ACCUMULATION PERSONS, JENNA L 13d
18701978 ANTIREFLECTIVE COATING AND USES THEREOF HO, WAI-GA DAVID 14d
18110960 METHOD AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS WANG, CHANG YU 16d
18869977 CUMULATIVE POLARIZATION COEXISTING WITH CONDUCTIVITY AT INTERFACIAL FERROELECTRICS LEBOEUF, JEROME LARRY 21d

Interview Candidates (12)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18701978 ANTIREFLECTIVE COATING AND USES THEREOF HO, WAI-GA DAVID 14d
19071967 FOUNDATION MODEL FOR ERROR CORRECTION CODES AND LEARNING LINEAR BLOCK ERROR CORRECTION CODES YANG, JEFFREY ANDREW
18768262 COMPOUNDS FOR THE TREATMENT OF GLYCOGEN STORAGE DISORDERS ROMERO, KRISTEN WANG
18742987 METHODS FOR DETECTING AND PREVENTING ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT TOTH, KAREN E
18674990 METHODS AND COMPOSITIONS FOR TREATING SPINAL CORD INJURY COUGHLIN, DANIEL F
18710002 FLUCONAZOLE-COX INHIBITOR HYBRIDS: A DUAL-ACTING CLASS OF ANTIFUNGAL AZOLES YOUNGBLOOD, WILLIAM JUSTIN
18277257 LYSOSOME-ASSOCIATED MEMBRANE PROTEIN TARGETING COMPOUNDS AND USES THEREOF SZNAIDMAN, MARCOS L
18245970 COMBINATION COMPOSITIONS HAVING ANTI-VIRAL ACTIVITIES AND USES THEREOF SZNAIDMAN, MARCOS L

Top Art Units

Art UnitApps
3791 3
1631 3
1628 2
1637 2
1723 2
1674 2
1675 2
2824 1
1619 1
2872 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19071967 FOUNDATION MODEL FOR ERROR CORRECTION CODES AND LEARNING LINEAR BLOCK ERROR CORRECTION CODES YANG, JEFFREY ANDREW §103 Non-Final OA Pending Mar 06, 2025
18869977 CUMULATIVE POLARIZATION COEXISTING WITH CONDUCTIVITY AT INTERFACIAL FERROELECTRICS LEBOEUF, JEROME LARRY 2824 §103§112 Final Rejection 21d Pending Nov 27, 2024
18768262 COMPOUNDS FOR THE TREATMENT OF GLYCOGEN STORAGE DISORDERS ROMERO, KRISTEN WANG §103§112 Non-Final OA Pending Jul 10, 2024
18742987 METHODS FOR DETECTING AND PREVENTING ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT TOTH, KAREN E 3791 §101§103§112 Non-Final OA Pending Jun 13, 2024
18674990 METHODS AND COMPOSITIONS FOR TREATING SPINAL CORD INJURY COUGHLIN, DANIEL F 1619 §102Other Non-Final OA Pending May 27, 2024
18710002 FLUCONAZOLE-COX INHIBITOR HYBRIDS: A DUAL-ACTING CLASS OF ANTIFUNGAL AZOLES YOUNGBLOOD, WILLIAM JUSTIN §102§112 Non-Final OA Pending May 14, 2024
18701978 ANTIREFLECTIVE COATING AND USES THEREOF HO, WAI-GA DAVID 2872 §103 Non-Final OA 14d Pending Apr 17, 2024
18694614 CANNABINOID-LIPID CONJUGATES, METHODS FOR PRODUCING THE SAME AND USES THEREOF FETTEROLF, BRANDON J 1626 §112 Non-Final OA Pending Mar 22, 2024
18605474 COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASE NEAGU, IRINA 1629 §102§103§112Other Non-Final OA 4d overdue Pending Mar 14, 2024
18419732 DIGITAL MICROFLUIDICS-LIKE MANIPULATION OF ELECTROKINETICALLY PRECONCENTRATED BIOPARTICLE/BIOMOLECULE PLUGS IN CONTINUOUS-FLOW HERBERT, MADISON TAYLOR §102§103§112 Non-Final OA Pending Jan 23, 2024
18573517 COMBINATION COMPOSITIONS FOR THE TREATMENT OF PATHOGEN INFECTIONS AND ASSOCIATED COMPLICATIONS LIEB, JEANETTE M 1654 §103 Non-Final OA Pending Dec 22, 2023
18563388 HIGH FREQUENCY SENSITIVE NEURAL NETWORK DANG, PHILIP §103 Final Rejection Pending Nov 22, 2023
18277257 LYSOSOME-ASSOCIATED MEMBRANE PROTEIN TARGETING COMPOUNDS AND USES THEREOF SZNAIDMAN, MARCOS L 1628 §112 Non-Final OA Pending Aug 15, 2023
18263795 LIPIDS SUITABLE FOR NUCLEIC ACID DELIVERY SAWYER, JENNIFER C 1691 §103 Non-Final OA Pending Aug 01, 2023
18038534 OPTIMIZED WOUND SITE OFFLOADING FOOTWEAR HALPRIN, MOLLY SARA 3791 §103 Final Rejection 121d overdue Pending May 24, 2023
18310044 GATA6-AS1 lncRNA FOR USE IN THERAPY GROOMS, TIFFANY NICOLE 1637 §101§103§112 Non-Final OA 70d Pending May 01, 2023
18245970 COMBINATION COMPOSITIONS HAVING ANTI-VIRAL ACTIVITIES AND USES THEREOF SZNAIDMAN, MARCOS L 1628 §101§103 Non-Final OA Pending Mar 20, 2023
18123413 METHOD AND SYSTEM FOR DESIGNING POLYNUCLEOTIDE SEQUENCES AND POLYNUCLEOTIDE SEQUENCES OBTAINED THEREBY LEONARD, ARTHUR S 1631 §102§103§112 Non-Final OA Pending Mar 20, 2023
18184249 METHOD FOR DETECTION OF MICROORGANISMS RODRIGUEZ-GARCIA, VALERIE 1621 §112 Final Rejection Pending Mar 15, 2023
18021577 MRI IN AN INHOMOGENEOUS FIELD WITH NO PULSED GRADIENTS CRUZ, IRIANA 2681 §102§103 Non-Final OA 56d Pending Feb 16, 2023
18002251 COMPOSITIONS COMPRISING AROMATIC DIPEPTIDES-BASED STRUCTURES ENCAPSULATING AN ESTERASE AND USES THEREOF RAMIREZ, DELIA M 1652 §103§112Other Final Rejection Pending Dec 16, 2022
17988893 MAdCAM-1 POLYPEPTIDES AND USES THEREOF LOCKARD, JON MCCLELLAND 1647 §103§112 Non-Final OA Pending Nov 17, 2022
17921035 CHIMERIC POLYPEPTIDES AND METHODS OF PREPARING SAME HOLLAND, PAUL J 1656 §112 Final Rejection 13d Pending Oct 24, 2022
17995610 CONCURRENT ELECTROPHORETIC DEPOSITION OF MEMBRANE-ELECTRODE-ASSEMBLY ROLDAN RAMOS, CHRISTIAN 1723 §103 Final Rejection 42d overdue Pending Oct 06, 2022
17952387 SYSTEM AND METHOD FOR MAPPING MUSCULAR ACTIVATION GLOVER, NELSON ALEXANDER 3791 §102§103§112 Final Rejection Pending Sep 26, 2022
17800345 ANTI- MUC1-SEA ANTIBODIES MIDDLETON, DANAYA L 1674 §102§112 Non-Final OA Pending Aug 17, 2022
17870607 RIBOSOME TERMINATION STRUCTURES AND USE THEREOF SHIBUYA, MARK LANCE 1631 §103§112 Non-Final OA Pending Jul 21, 2022
17870029 MOLECULES AND METHODS FOR INCREASED TRANSLATION ABBOTT, KODYE LEE 1634 §102§103§112 Non-Final OA 12d Pending Jul 21, 2022
17788003 METHODS AND ARRAYS FOR IDENTIFYING THE CELL OR TISSUE ORIGIN OF DNA LAFAVE, ELIZABETH ROSE 1684 §103 Final Rejection Pending Jun 22, 2022
17783276 BACTERIA-ASSOCIATED VOLATILE ORGANIC COMPOUNDS BOECKELMAN, JACOB A 1655 §101§112 Final Rejection Pending Jun 08, 2022
17831232 INTEGRATED DRUG DISCOVERY PLATFORM FOR PROTEIN MISFOLDING DISORDERS ASSOCIATED WITH METABOLITE ACCUMULATION PERSONS, JENNA L 1637 §102§112Other Non-Final OA 13d Pending Jun 02, 2022
17780536 COMPOSITION-OF-MATTER FOR EXTRUSION OF ELECTROCHEMICAL SYSTEM SMITH, JEREMIAH R 1723 §102§103 Non-Final OA 42d overdue Pending May 27, 2022
17637682 METHODS AND COMPOSITIONS FOR TREATING PAX6-DEFICIENCY RELATED DISEASE PATTERSON, SARAH COOPER 1675 §112 Final Rejection Pending Feb 23, 2022
17675910 PEPTIDES FOR THE TREATMENT OF RENAL DISORDERS COFFA, SERGIO 1658 §103§112 Non-Final OA 30d overdue Pending Feb 18, 2022
17394008 MESENCHYMAL CELL-DERIVED EXOSOMES TO TREAT NEUROLOGICAL DISORDERS BARRON, SEAN C 1653 §103§112Other Final Rejection 34d Pending Aug 04, 2021
17273857 METHOD OF PRODUCING METAL NANOPARTICLES AND USES THEREOF PURDY, KYLE A 1611 §103 Non-Final OA 27d Pending Mar 05, 2021
17142072 METHODS AND COMPOSITIONS FOR MODULATING MYELOPEROXIDASE (MPO) EXPRESSION MIDDLETON, DANAYA L 1674 §102§112Other Non-Final OA Pending Jan 05, 2021
16959878 TRANSGENIC EUKARYOTIC ORGANISMS AND METHODS FOR GENDER SELECTION LEONARD, ARTHUR S 1631 §103 Final Rejection Pending Jul 02, 2020
16919134 CONTROL OF THE CONCENTRATION-POLARIZATION LAYER LENGTH IN A MICROCHANNEL-MEMBRANE SYSTEM KOLTONOW, ANDREW ROBERT 1795 §103§112 Final Rejection 22d Pending Jul 02, 2020
18570211 MULTI-LAYERED MODULAR ORGAN-ON-A-CHIP PLATFORM CARREON, ADRIAN JOHN §103 Non-Final OA Pending Dec 14, 2023
18223730 COMPOSITIONS AND METHODS FOR TREATING A DISEASE JOHANSEN, PETER N. 1644 §102§103 Final Rejection Pending Jul 19, 2023
18110960 METHOD AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS WANG, CHANG YU 1675 §103§112 Non-Final OA 16d Pending Feb 17, 2023
18110934 ENGINEERED PROTEIN DELIVERY PLATFORM AND USE THEREOF FOR ANTIBACTERIAL TREATMENTS KANE, TREVOR LOGAN 1657 §103§112Other Final Rejection Pending Feb 17, 2023
18167381 HIGH DIMENSIONAL SURROGATE MODELING FOR LEARNING UNCERTAINTY WU, NICHOLAS S 2148 §103 Final Rejection Pending Feb 10, 2023

Managing Ramot At Tel-aviv University Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month